On the origin of the stronger binding of PIB over Thioflavin T to protofibrils of the Alzheimer Amyloid-β peptide: A molecular dynamics study

Biophysical Journal

Volumn 100, Issue 5, 2011, Pages 1316-1324

  Wu, Chun ^a   Bowers, Michael T ^a   Shea, Joan Emma ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953839293     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2011.01.058     Document Type: Article

References (40)

1. Jorm, A. E, and D. Jolley. 1998. The incidence of dementia: a metaanalysis. Neurology. 51:728-733.
2. Drzezga, A. 2010. Amyloid-plaque imaging in early and differential diagnosis of dementia. Ann. Nucl. Med. 24:55-66.
3. Hardy, J., and D. J. Selkoe. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:353-356. (Pubitemid 34790756)
4. Selkoe, D. J. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:741-766. (Pubitemid 32267077)
5. Dahlgren, K. N., A. M. Manelli, M. J. LaDu. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277:32046-32053. (Pubitemid 34969015)
6. Furumoto, S., N. Okamura, Y. Kudo. 2007. Recent advances in the development of amyloid imaging agents. Curr. Top. Med. Chem. 7:1773-1789. (Pubitemid 350130996)
7. Wolfe, L. S., M. F. Calabrese, Y. Xiong. 2010. Protein- inducedphotophysical changes to the amyloid indicator dye thioflavin T. Proc. Natl. Acad. Sci. USA. 107:16863-16868.
8. Sulatskaya, A. I., A. A. Maskevich, ..., K. K. Turoverov. 2010. Fluorescence quantum yield of thioflavin T in rigid isotropic solution and incorporated into the amyloid fibrils. PLoS ONE. 5:e15385.
9. Stsiapura, V. I., A. A. Maskevich, ..., I. M. Kuznetsova. 2007. Computational study of thioflavin T torsional relaxation in the excited state. J. Phys. Chem. A. 111:4829-4835. (Pubitemid 46960782)
10. Stsiapura, V. I., A. A. Maskevich, O. V. Buganov. 2010. Charge transfer process determines ultrafast excited state deactivation of thioflavin T in low-viscosity solvents. J. Phys. Chem. A. 114:8345-8350.
11. Raji, C. A., J. T. Becker, W. E. Klunk. 2008. Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh compound B. J. Neurosci. Methods. 172:277-282.
12. Mathis, C. A., Y. M. Wang, ..., W. E. Klunk. 2003. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 46:2740-2754. (Pubitemid 36702542)
13. Mathis, C., D. Holt, W. Klunk. 2004. Evaluation of a potent thioflavin-T analog for in vivo imaging of amyloid with PET. Neurobiol. Aging. 25:248-249.
14. Klunk, W. E., Y. M. Wang, ..., C. A. Mathis. 2001. Uncharged thioflavin-T derivatives bind to amyloid-β protein with high affinity and readily enter the brain. Life Sci. 69:1471-1484. (Pubitemid 32786721)
15. Rosen, R. F., B. J. Ciliax, L. C. Walker. 2010. Deficient highaffinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol. 119:221-233.
16. Groenning, M. 2009. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J. Chem. Biol. 3:1-18.
17. Petkova, A. T., W. M. Yau, and R. Tycko. 2006. Experimentalconstraints on quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry. 45:498-512. (Pubitemid 43100415)
18. Lührs, T., C. Ritter, .., R. Riek. 2005. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. USA. 102:17342-17347.
19. Ma, B. Y., and R. Nussinov. 2002. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ 16-22, Aβ 16-35, and Aβ 10-35): sequence effects. Proc. Natl. Acad. Sci. USA. 99:14126-14131. (Pubitemid 35257636)
20. Buchete, N. V., and G. Hummer. 2007. Structure and dynamics of parallel β-sheets, hydrophobic core, and loops in Alzheimer's A β fibrils. Biophys. J. 92:3032-3039. (Pubitemid 46684564)
21. Chen, B., K. R. Thurber, R. Tycko. 2009. Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc. Natl. Acad. Sci. USA. 106:14339-14344.
22. Buchete, N. V., R. Tycko, and G. Hummer. 2005. Molecular dynamics simulations of Alzheimer's β-amyloid protofilaments. J. Mol. Biol. 353:804-821. (Pubitemid 41460541)
23. Zheng, J., H. Jang, .., R. Nussinov. 2007. Modeling the Alzheimer Aβ 17-42 fibril architecture: tight intermolecular sheet-sheet association and intramolecular hydrated cavities. Biophys. J. 93:3046-3057. (Pubitemid 350103369)
24. Duan, Y., C. Wu, ..., P. Kollman. 2003. A point-charge force field for molecular mechanics simulations of proteins based on condensedphase quantum mechanical calculations. J. Comput. Chem. 24:1999-2012.
25. Hornak, V., R. Abel, . , C. Simmerling. 2006. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 65:712-725. (Pubitemid 44583220)
26. Jorgensen, W. L., J. Chandrasekhar, ..., M. L. Klein. 1983. Comparisons of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
27. Wu, C., Z. X. Wang, ..., Y. Duan. 2007. Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. J. Am. Chem. Soc. 129:1225-1232. (Pubitemid 46208593)
28. Bayly, C. I., P. Cieplak, P. A. Kollman. 1993. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges - the RESP model. J. Phys. Chem. 97:10269-10280.
29. Wang, J. M., R. M. Wolf, D. A. Case. 2004. Development and testing of a general Amber force field. J. Comput. Chem. 25:1157-1174.
30. Takeda, T., W. L. E. Chang, . , D. K. Klimov. 2010. Binding of nonsteroidal anti-inflammatory drugs to Aβ fibril. Proteins. 78:2849-2860.
31. Wu, C., Z. X. Wang, J. E. Shea. 2008. The binding of thioflavin T and its neutral analog BTA-1 to protofibrils of the Alzheimer's disease Aβ (16-22) peptide probed by molecular dynamics simulations. J. Mol. Biol. 384:718-729.
32. Wu, C., M. Biancalana, J. E. Shea. 2009. Binding modes of thioflavin-T to the single-layer β-sheet of the peptide self-assembly mimics. J. Mol. Biol. 394:627-633.
33. Mathis, C. A., D. P. Holt, W. E. Klunk. 2001. A lipophilic C-11-labeled derivative of thioflavin-T for amyloid assessments in Alzheimer's disease. J. Nucl. Med. 42:113P.
34. Raman, E. P., T. Takeda, and D. K. Klimov. 2009. Molecular dynamics simulations of ibuprofen binding to Aβ peptides. Biophys. J. 97:2070-2079.
35. Biancalana, M., K. Makabe, . , S. Koide. 2009. Molecular mechanism of thioflavin-T binding to the surface of β-rich peptide self-assemblies. J. Mol. Biol. 385:1052-1063.
36. Dote, J., D. Kivelson, and R. N. Schwartz. 1981. A molecular quasihydrodynamic free-space model for molecular rotational relaxation in liquids. J. Phys. Chem. 85:2169-2180.
37. Lockhart, A., L. Ye, J. Brown. 2005. Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on β-amyloid peptide fibrils. J. Biol. Chem. 280:7677-7684. (Pubitemid 40349660)
38. Lockhart, A., J. R. Lamb, T. G. Beach. 2007. PIB is a non-specific imaging marker of amyloid-β (Ab) peptide-related cerebral amyloidosis. Brain. 130:2607-2615. (Pubitemid 47511709)
39. Krebs, M. R. H., E. H. C. Bromley, and A. M. Donald. 2005. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J. Struct. Biol. 149:30-37. (Pubitemid 40051399)
40. Agdeppa, E. D., V. Kepe, J. R. Barrio. 2001. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease. J. Neurosci. 21:RC189.